Shares of Definitive Healthcare Corp. (NASDAQ:DH – Get Free Report) gapped down prior to trading on Wednesday after Stifel Nicolaus lowered their price target on the stock from $12.00 to $11.00. The stock had previously closed at $9.19, but opened at $7.76. Stifel Nicolaus currently has a buy rating on the stock. Definitive Healthcare shares last traded at $8.00, with a volume of 509,388 shares traded.
Several other research analysts have also recently weighed in on the company. Morgan Stanley cut their price objective on Definitive Healthcare from $15.50 to $9.50 and set an “overweight” rating on the stock in a research report on Friday, November 3rd. Needham & Company LLC cut Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday. Canaccord Genuity Group reaffirmed a “hold” rating and set a $10.00 price target on shares of Definitive Healthcare in a research report on Friday, January 5th. Finally, Canaccord Genuity Group cut Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. Seven analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $11.61.
Institutional Trading of Definitive Healthcare
Institutional investors have recently added to or reduced their stakes in the stock. Victory Capital Management Inc. bought a new position in Definitive Healthcare in the 2nd quarter worth about $1,760,000. Lombard Odier Asset Management Europe Ltd bought a new position in shares of Definitive Healthcare during the 2nd quarter valued at about $495,000. Bank of New York Mellon Corp increased its position in shares of Definitive Healthcare by 10.8% during the 2nd quarter. Bank of New York Mellon Corp now owns 976,173 shares of the company’s stock valued at $10,738,000 after purchasing an additional 94,850 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Definitive Healthcare by 53.8% during the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 112,476 shares of the company’s stock valued at $1,237,000 after purchasing an additional 39,333 shares during the last quarter. Finally, Wrapmanager Inc. increased its position in shares of Definitive Healthcare by 37.8% during the 2nd quarter. Wrapmanager Inc. now owns 32,938 shares of the company’s stock valued at $362,000 after purchasing an additional 9,041 shares during the last quarter.
Definitive Healthcare Price Performance
The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.55 and a current ratio of 2.55. The stock has a market capitalization of $969.03 million, a P/E ratio of -5.14, a price-to-earnings-growth ratio of 4.81 and a beta of 1.39. The firm has a 50-day moving average price of $8.81 and a 200 day moving average price of $9.00.
Definitive Healthcare (NASDAQ:DH – Get Free Report) last posted its quarterly earnings results on Thursday, November 2nd. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.01). Definitive Healthcare had a positive return on equity of 0.50% and a negative net margin of 73.75%. The company had revenue of $65.33 million for the quarter, compared to the consensus estimate of $63.60 million. On average, analysts expect that Definitive Healthcare Corp. will post 0.07 EPS for the current year.
Definitive Healthcare Company Profile
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.